




Searching News Database: Theravance
HSMN NewsFeed - 7 Mar 2024
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
HSMN NewsFeed - 15 Sep 2021
Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
HSMN NewsFeed - 27 Mar 2017
Bridge Medicines Appoints William J. Polvino, M.D., As Chief Executive Officer
Bridge Medicines Appoints William J. Polvino, M.D., As Chief Executive Officer
HSMN NewsFeed - 9 May 2016
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
HSMN NewsFeed - 18 Aug 2015
Radius Health Announced That it Has Appointed Catherine Friedman to the Board of Directors
Radius Health Announced That it Has Appointed Catherine Friedman to the Board of Directors
HSMN NewsFeed - 13 Jun 2014
Theravance, Inc. Appoints George B. Abercrombie as Senior Vice President, Corporate Partnerships, Commercial
Theravance, Inc. Appoints George B. Abercrombie as Senior Vice President, Corporate Partnerships, Commercial
HSMN NewsFeed - 20 Sep 2013
RELVAR(TM) ELLIPTA(TM) Gains Approval in Japan for the Treatment of Asthma
RELVAR(TM) ELLIPTA(TM) Gains Approval in Japan for the Treatment of Asthma
HSMN NewsFeed - 6 Sep 2013
Oncothyreon Announces Appointment of Ted W. Love, M.D. to Board of Directors
Oncothyreon Announces Appointment of Ted W. Love, M.D. to Board of Directors
HSMN NewsFeed - 13 Jul 2012
GSK and Theravance Announce Regulatory Submissions for FF/VI in the US and Europe
GSK and Theravance Announce Regulatory Submissions for FF/VI in the US and Europe
HSMN NewsFeed - 2 Jun 2011
GSK and Theravance Announce Results of Two Pivotal Phase III Studies for Relovair(TM) in COPD
GSK and Theravance Announce Results of Two Pivotal Phase III Studies for Relovair(TM) in COPD
HSMN NewsFeed - 23 Sep 2010
BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
HSMN NewsFeed - 2 Dec 2009
LifeCycle Pharma Promotes Dr. William J. Polvino as New President and Chief Executive Officer
LifeCycle Pharma Promotes Dr. William J. Polvino as New President and Chief Executive Officer
HSMN NewsFeed - 27 Nov 2009
Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia
Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia
HSMN NewsFeed - 5 Nov 2009
Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
HSMN NewsFeed - 13 Jan 2009
Jennerex Appoints Samantha Miller as Vice President of Corporate Development
Jennerex Appoints Samantha Miller as Vice President of Corporate Development
HSMN NewsFeed - 29 Jan 2008
KaloBios Strengthens Development Expertise With Additions to Senior Management Team
KaloBios Strengthens Development Expertise With Additions to Senior Management Team
HSMN NewsFeed - 27 Dec 2007
Theravance Receives Notice of Possible Telavancin Review by FDA Advisory Committee
Theravance Receives Notice of Possible Telavancin Review by FDA Advisory Committee
HSMN NewsFeed - 5 Dec 2007
Theravance Announces Positive Topline Results In Phase 3 Telavancin Hospital-Acquired Pneumonia Program
Theravance Announces Positive Topline Results In Phase 3 Telavancin Hospital-Acquired Pneumonia Program
HSMN NewsFeed - 8 Nov 2007
Jennerex Appoints Bob Ingram Special Advisor and Hires Marty Glick as EVP, Corporate Strategy
Jennerex Appoints Bob Ingram Special Advisor and Hires Marty Glick as EVP, Corporate Strategy
HSMN NewsFeed - 31 Jul 2007
Theravance Announces Appointment of Leonard M. Blum as Chief Commercial Officer
Theravance Announces Appointment of Leonard M. Blum as Chief Commercial Officer
HSMN NewsFeed - 27 Mar 2007
Sapphire Therapeutics, Inc. Promotes William Polvino to CEO, Herb Conrad Elected Chairman of the Board
Sapphire Therapeutics, Inc. Promotes William Polvino to CEO, Herb Conrad Elected Chairman of the Board
Additional items found! 18

Members Archive contains
18 additional stories matching:
Theravance
(Password required)
Theravance
(Password required)